Incorporation of empagliflozin in a closed-loop, automated insulin pump for patients with type 1 diabetes may allow for the elimination of carbohydrate counting.
Researchers sought to identify whether there were any functional deficits in the developing brains of children with type 1 diabetes due to episodes of hyperglycemia.
At the Endocrine Society’s annual meeting, ENDO 2021, Seema Kumar from the Mayo Clinic presented a review covering the evaluation and assessment of pediatric obesity and type 2 diabetes mellitus.
Type 1 diabetes in pregnancy is associated with maternal hyperglycemia with some women developing preeclampsia and requiring an assisted birth or operative delivery.
Although different insulin analogs, pumps, and sensors have been proven to work, studies have shown that few children and adolescents achieve recommended HbA1c targets.
Mortality risk from infection with COVID-19 among middle-aged adults with T2D is elevated compared with adults without diabetes and is the equivalent of adding 20 years of chronological age to assessing overall related death risk.
About 20% of patients with diabetes hospitalized with COVID-19 die within 28 days and about 50% are discharged, and predictors of death and discharge have been identified.
Physicians and parents have ranked important features of conducting type 1 diabetes screening tests, which is crucial due to the increasing prevalence of type 1 diabetes in children.
Remote digital monitoring is relatively new in diabetes care. It can be either complimentary to care or intrusive. In this study, researchers focus on concerns patients have from privacy to wearability.
A study designed to evaluate the impact of coronavirus disease 2019 lockdown on people living with type 1 diabetes, shows patients were able to improve their glycemic control indices.
In addition to a diabetes diagnosis, people with a history of smoking and who have specific comorbidities, such as heart disease, liver disease, and chronic lower respiratory disease, are at increased risk of poorer COVID-19 outcomes.
The Endocrine Society is calling for immediate action by policymakers to address the underlying factors responsible for the rising cost of insulin, a life-saving drug taken by 7.4 million people in the United States.
